
Quantum-Si (QSI) Stock Forecast & Price Target
Quantum-Si (QSI) Analyst Ratings
Bulls say
Quantum-Si Inc. has developed a proprietary universal single-molecule detection platform for Next-Generation Protein Sequencing (NGPS), enhancing its position in the life sciences sector. The company's advancements, particularly with the V4 Sequencing Kit, are expected to facilitate broader adoption of its Platinum and PlatinumPro instruments, enabling new applications such as antibody sequencing and the analysis of complex mixtures. These improvements in sequencing consumables and platforms are anticipated to drive significant growth in utilization levels, indicating a positive outlook for the company's future performance.
Bears say
Quantum-Si Inc faces significant challenges that contribute to a negative outlook on its stock, primarily due to a highly competitive landscape featuring numerous established players in the proteomics research sector. Additionally, the company has a record of operating losses that are projected to persist, coupled with uncertainties surrounding its commercial launch and reliance on external partners for manufacturing and key supplies. Furthermore, concerns regarding the robustness of its intellectual property and the relatively unproven nature of its technology further exacerbate the risks to its financial projections and valuation.
This aggregate rating is based on analysts' research of Quantum-Si and is not a guaranteed prediction by Public.com or investment advice.
Quantum-Si (QSI) Analyst Forecast & Price Prediction
Start investing in Quantum-Si (QSI)
Order type
Buy in
Order amount
Est. shares
0 shares